The phrase "asynchronous treatment" is correct and usable in written English.
It can be used in contexts related to healthcare, therapy, or any situation where treatment or intervention occurs without simultaneous interaction or real-time communication.
Example: "The clinic offers asynchronous treatment options, allowing patients to receive care at their convenience without the need for immediate appointments."
Alternatives: "delayed treatment" or "non-synchronous therapy".
We investigated the response of an ensemble of 1000 asynchronous BNs to treatment with INS (including the BN depicted in Figure 2(A) until all BNs reached a steady state.
This study included a randomized controlled trial (RCT) on an asynchronous web-based treatment program with intensive therapeutic support (25 scheduled clinician feedback moments) among Dutch patients with BN.
Thus, we induced DSB (in asynchronous cultures) by galactose treatment in the JKM179 donor-less strain and performed a time-course-based ChIP experiment for histones, their post-translational modifications and histone variants, at regions near the DSB and at an unrelated locus (ARS315) as a control.
Treatment of asynchronous populations with 5 μ M NU6102 arrested cells at the G2/M boundary with an increase in G2/M fraction in MCF7 (2.33-fold*), MMU2 (1.95-fold**) and LCC9 (3.4-fold**) cell lines compared with the DMSO control.
We first blocked asynchronous cells in G2 via treatment with a CDK1 inhibitor9 (RPE1 cells expressing zyxin-GFP).
The simulation results verify that this treatment of the asynchronous interference can perform very well.
G1/S phases or G2/M phases-arrested cells were obtained after a 14 h treatment of an asynchronous population of cells with 2.5 mM thymidine (Sigma) or with 800 nM of nocodazole (Tocris), respectively.
Fold changes and implementation of fold‐change cut-offs were based on pairwise comparisons between each treatment and an asynchronous population.
Therefore, the reduction of these two asynchronous antigens, CD34+/CD117+ in response to treatment with 40 or 80 mg kg−1 of Pho-s (40.4±2.8), (69±1.4%), or 1 mg kg−1 ATRA (14.6±2.5), respectively constitute a notable antitumor effect.
Increased sensitivity to taxol was also induced by combined treatment with MK-1775 in asynchronous cell populations of A2780 and MCF-7, a breast cancer cell line (Supplementary Figure 7).
